Fixed-Dose Recombinant Urate Oxidase in the Treatment of Paediatric Tumour Lysis Syndrome: A Regional Cancer Centre Experience

BACKGROUND: Tumor lysis syndrome (TLS) is an oncologic emergency commonly seen in children with hemato-lymphoid malignancies. Recombinant urate oxidase (RUO) is used in both the prophylaxis and treatment of TLS. However, in resource-constrained countries, its role is mostly limited to the treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: L, Appaji, Reddy, Jyothi. M, Chebbi, Pooja Gujjal, Kumar, Nuthan, AR, Arun Kumar, M, Padma, B S, Aruna Kumari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080352/
https://www.ncbi.nlm.nih.gov/pubmed/34967569
http://dx.doi.org/10.31557/APJCP.2021.22.12.3897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080352/
https://www.ncbi.nlm.nih.gov/pubmed/34967569
http://dx.doi.org/10.31557/APJCP.2021.22.12.3897

Ejemplares similares